Walter Moos

Walter Moos

Direktor/Vorstandsmitglied bei RIGEL PHARMACEUTICALS, INC.

Vermögen: 563 211 $ am 31.05.2026

71 Jahre
Health Technology
Commercial Services
Finance

Profil

Walter H.
Moos
is the founder of Pandect Bioventures Management LLC, founded in 2018, serving as Managing Director.
Current jobs include Chairman at Keystone Symposia since 2000; Independent Director at Rigel Pharmaceuticals, Inc. since 1997; Director at Circle Pharma, Inc. since 2016; Member of the Board of Directors at Aprinoia Therapeutics, Inc. since 2018; Director at Valitor, Inc.; and Director at Organos, Inc. Former jobs include Chairman & Chief Executive Officer at MitoKor, Inc. from 1997 to 2004; Board Member and Acting/Interim CEO at Alnis Biosciences, Inc. from 2003 to 2005; Chairman at ShangPharma Innovation, Inc. in 2020; Director at MIGENIX, Inc. from 2004 to 2008; Director at Oncologic, Inc.; Director at Critical Path Institute; Director at Amunix, Inc.; Vice President at Chiron Corp.
from 1991 to 1997; VP-Neuroscience & Biological Chemistry at Pfizer Inc. from 1982 to 1991; Vice President-Neuroscience & Biological Chemistry at Warner-Lambert Co. from 1982 to 1991; Board Member at Onyx Pharmaceuticals, Inc. from 1993 to 1997; Board Member at Biotechnology Innovation Organization from 2001 to 2003; Executive Advisor at Aduro BioTech, Inc. from 2016 to 2020; Board Member at Anterion Therapeutics, Inc. from 2003 to 2005; President-Biosciences at SRI International from 2015 to 2016; Board Member and Chair at Mimotopes Pty Ltd.; Board Member at Axiom Biotechnologies, Inc. from 2001 to 2002; Advisor at Red Abbey Venture Partners LLC; Member of the Scientific Advisory Board at Global Blood Therapeutics, Inc. from 2016 to 2022; Board Member at Virginia University Research Partnership, Inc. from 2007 to 2015; Executive Advisor at Chinook Therapeutics, Inc. from 2016 to 2020; and Advisory Board Member at Cafe Scientifique Silicon Valley from 2007 to 2013.
Education includes an undergraduate degree from Harvard University conferred in 1976 and a doctorate from the University of California, Berkeley conferred in 1982.

Bekannte Unternehmensbeteiligungen

UnternehmenDatumAnzahl der AktienBewertungDatum der Bewertung
15.05.2026 18 472 ( 0,1 % ) 563 211 $ 31.05.2026

Aktive Positionen von Walter Moos

UnternehmenPositionBeginn
RIGEL PHARMACEUTICALS, INC. Direktor/Vorstandsmitglied 01.03.1997
Vorsitzender 01.01.2000
Gründer 01.10.2018
Direktor/Vorstandsmitglied 01.01.2018
Direktor/Vorstandsmitglied -
Direktor/Vorstandsmitglied -
Direktor/Vorstandsmitglied -

Ehemalige bekannte Positionen von Walter Moos

UnternehmenPositionEnde
Vorstandsvorsitzender 01.06.2020
Berater 23.12.2022
░░░░░░ ░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░ ░░░░░░░░░░
Sehen Sie sich die Erfahrung von Walter Moos im Detail an

Ausbildung von Walter Moos

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen

79

Beziehungen ersten Grades

31

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Unternehmensverbindungen

Private Unternehmen31

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Electronic Technology

Commercial Services

Consumer Services

Health Technology

Commercial Services

Consumer Services

Finance

Commercial Services

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Virginia University Research Partnership, Inc.

Finance

Health Technology

Health Technology

Finance

Health Technology

Commercial Services

Cafe Scientifique Silicon Valley

  1. Börse
  2. Insiders
  3. Walter Moos